Back to Journals » OncoTargets and Therapy » Volume 11

Original Research

CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway

       
Total article views   HTML views PDF downloads Totals
8,703 Dovepress* 7,545+ 724 8,269
PubMed Central* 1,158 237 1,395
Totals 8,703 961 9,664
*Since 25 September 2018

View citations on PubMed and Google Scholar